Svenja Debey

2.0k total citations
12 papers, 1.6k citations indexed

About

Svenja Debey is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Svenja Debey has authored 12 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Cancer Research. Recurrent topics in Svenja Debey's work include Inflammatory mediators and NSAID effects (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Molecular Biology Techniques and Applications (2 papers). Svenja Debey is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Molecular Biology Techniques and Applications (2 papers). Svenja Debey collaborates with scholars based in Germany, United Kingdom and United States. Svenja Debey's co-authors include Joachim L. Schultze, Alexey Popov, Marc Beyer, Jaqueline Bautor, Jane E. Parker, Michael Bartsch, Paweł Bednarek, Enrico Gobbato, Thomas Zander and Michael Hallek and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Svenja Debey

12 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Svenja Debey Germany	11	646	485	363	291	207	12	1.6k
Michel Dréano Switzerland	23	512 0.8×	649 1.3×	41 0.1×	398 1.4×	54 0.3×	41	1.6k
Barbara Bertocci France	18	830 1.3×	1.1k 2.3×	60 0.2×	176 0.6×	93 0.4×	33	2.0k
Mary E. Ballestas United States	27	323 0.5×	716 1.5×	89 0.2×	1.4k 4.7×	38 0.2×	33	2.5k
Italo Tempera United States	23	346 0.5×	546 1.1×	119 0.3×	1.0k 3.5×	21 0.1×	53	1.6k
William A. Hanlon United States	12	430 0.7×	660 1.4×	71 0.2×	181 0.6×	23 0.1×	20	1.4k
Haiyan Xiao China	21	593 0.9×	679 1.4×	19 0.1×	200 0.7×	111 0.5×	90	1.5k
Marija Mostarica‐Stojković Serbia	20	465 0.7×	255 0.5×	33 0.1×	196 0.7×	29 0.1×	41	1.1k
Camillo Mancini Italy	18	274 0.4×	476 1.0×	147 0.4×	164 0.6×	23 0.1×	40	985
Oleg Denisenko United States	24	198 0.3×	1.9k 3.8×	139 0.4×	190 0.7×	50 0.2×	54	2.4k
Betsabeh Khoramian Tusi United States	11	390 0.6×	1.6k 3.2×	61 0.2×	106 0.4×	47 0.2×	16	2.0k

Countries citing papers authored by Svenja Debey

Since Specialization

Citations

This map shows the geographic impact of Svenja Debey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svenja Debey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svenja Debey more than expected).

Fields of papers citing papers by Svenja Debey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svenja Debey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svenja Debey. The network helps show where Svenja Debey may publish in the future.

Co-authorship network of co-authors of Svenja Debey

This figure shows the co-authorship network connecting the top 25 collaborators of Svenja Debey. A scholar is included among the top collaborators of Svenja Debey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svenja Debey. Svenja Debey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Pallasch, Christian P., Janine Schwamb, Alexandra Schulz, et al.. (2007). Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia. 22(3). 585–592. 84 indexed citations

Claßen, Sabine, Thomas Zander, Daniela Eggle, et al.. (2007). Human Resting CD4+ T Cells Are Constitutively Inhibited by TGFβ under Steady-State Conditions. The Journal of Immunology. 178(11). 6931–6940. 32 indexed citations

Chemnitz, Jens M., Julia Driesen, Sabine Claßen, et al.. (2006). Prostaglandin E2 Impairs CD4+ T Cell Activation by Inhibition of lck: Implications in Hodgkin's Lymphoma. Cancer Research. 66(2). 1114–1122. 84 indexed citations

Debey, Svenja, Thomas Zander, Benedikt Brors, et al.. (2006). A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials. Genomics. 87(5). 653–664. 60 indexed citations

Popov, Alexey, Zeinab Abdullah, Claudia Wickenhauser, et al.. (2006). Indoleamine 2,3-dioxygenase–expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. Journal of Clinical Investigation. 116(12). 3160–3170. 121 indexed citations

Bartsch, Michael, Enrico Gobbato, Paweł Bednarek, et al.. (2006). Salicylic Acid–Independent ENHANCED DISEASE SUSCEPTIBILITY1 Signaling inArabidopsisImmunity and Cell Death Is Regulated by the MonooxygenaseFMO1and the Nudix HydrolaseNUDT7. The Plant Cell. 18(4). 1038–1051. 405 indexed citations

Bergwelt‐Baildon, Michael S. von, Alexey Popov, Tomo Šarić, et al.. (2006). CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood. 108(1). 228–237. 187 indexed citations

Beyer, Marc, Matthias Kochanek, Kamruz Darabi, et al.. (2005). Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood. 106(6). 2018–2025. 395 indexed citations

Debey, Svenja, Martin Hellmich, Birgit Gathof, et al.. (2004). Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. The Pharmacogenomics Journal. 4(3). 193–207. 169 indexed citations

10.

Debey, Svenja, Jutta Meyer-Kirchrath, & Karsten Schrör. (2003). Regulation of cyclooxygenase-2 expression by iloprost in human vascular smooth muscle cells. Biochemical Pharmacology. 65(6). 979–988. 22 indexed citations

11.

Meyer-Kirchrath, Jutta, et al.. (2003). Gene expression profile of the Gs-coupled prostacyclin receptor in human vascular smooth muscle cells. Biochemical Pharmacology. 67(4). 757–765. 30 indexed citations

12.

Debey, Svenja, Lutz Kirchrath, Karsten Schrör, & Jutta Meyer-Kirchrath. (2003). Iloprost down-regulates the expression of the growth regulatory gene Cyr61 in human vascular smooth muscle cells. European Journal of Pharmacology. 474(2-3). 161–164. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact